Your browser doesn't support javascript.
loading
Development and optimization of a cell screening system for farnesoid X receptor agonist / 生物工程学报
Chinese Journal of Biotechnology ; (12): 359-371, 2023.
Article in Chinese | WPRIM | ID: wpr-970380
ABSTRACT
This study aims to develop an improved cell screening system for farnesoid X receptor (FXR) agonists based on a dual luciferase reporter gene system. FXR response element (FXRE) fragments from FXR target genes were cloned and inserted into upstream of firefly luciferase (Luc) gene in the plasmid pGL4-luc2P-Hygro. In combination with the internal reference plasmid containing renilla luciferase, a dual luciferase reporter gene system was developed and used for high throughput screening of FXR agonists. After studying the effects of over-expression of RXR, mouse or human FXR, various FXRE fragments, and different ratio of FXR plasmid amount to reporter gene plasmid, induction efficiency of the screening system was optimized by the known FXR agonist GW4064, and Z factor for the system reached 0.83 under optimized conditions. In summary, an improved cell screening system based on double luciferase reporter gene detection system was developed to facilitate the discovery of FXR agonists, where a new enhanced FXRE element was formed by a superposition of multiple FXRE fragments from FXR target genes, instead of a superposition of traditional IR-1 (inverted repeats-1) fragments.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Transcription Factors / Receptors, Cytoplasmic and Nuclear / Genes, Reporter / DNA-Binding Proteins / Luciferases Limits: Animals / Humans Language: Chinese Journal: Chinese Journal of Biotechnology Year: 2023 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Transcription Factors / Receptors, Cytoplasmic and Nuclear / Genes, Reporter / DNA-Binding Proteins / Luciferases Limits: Animals / Humans Language: Chinese Journal: Chinese Journal of Biotechnology Year: 2023 Type: Article